10 Biggest Price Target Changes For Monday
UBS lifted the price target on Pfizer Inc. (NYSE: PFE) from $52 to $60. Pfizer shares rose 1.5% to $53.56 in pre-market trading.
Goldman Sachs Downgrades Timken, Cuts Price Target By 13%
Goldman Sachs analyst Joe Ritchie downgraded Timken Co (NYSE:TKR) to Neutral from Buy and lowered the price target to $73 (an upside of…
Goldman Sachs Downgrades Timken to Neutral, Lowers Price Target to $73
Goldman Sachs analyst Joe Ritchie downgrades Timken (NYSE:TKR) from Buy to Neutral and lowers the price target from $84 to $73.
Timken Leverages Rollon Brand For Growth In Linear Motion
Timken Co (NYSE:TKR) stated it is experiencing strong growth in its linear motion product line, with 2021 sales expected to…
Timken Q3 EPS $1.18 Beats $1.17 Estimate, Sales $1.04B Beat $1.01B Estimate
Timken (NYSE:TKR) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.17 by 0.85 percent. This is a 4.42 percent increase over earnings of $1.13 per share from the same period
Earnings Scheduled For November 1, 2021
Companies Reporting Before The Bell
• ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter.
A Preview Of Timken’s Earnings
Timken (NYSE:TKR) is set to give its latest quarterly earnings report on Monday, 2021-11-01. Here's what investors need to know before the announcement.
Analysts estimate that Timken will likely report an Earnings Per Share (EPS) of $1.17
Morgan Stanley Lowers Price Target For Several Machinery Stocks
Morgan Stanley analyst Courtney Yakavonis lowered the Price target for several Machinery stocks.
Morgan Stanley Maintains Equal-Weight on Timken, Lowers Price Target to $76
Morgan Stanley analyst Courtney Yakavonis maintains Timken (NYSE:TKR) with a Equal-Weight and lowers the price target from $84 to $76.